Matches in SemOpenAlex for { <https://semopenalex.org/work/W96157772> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W96157772 endingPage "554" @default.
- W96157772 startingPage "549" @default.
- W96157772 abstract "The mode of action of slow-acting anti-rheumatic drugs (SAARDs) is complex but may often include effects on cytokine (interleukin-1, IL-1, and tumour necrosis factor, TNF) production by monocytes/macrophages. Different SAARDs may have variable effects on cytokine production in vitro depending on the concentration of drug, the presence of other SAARDs and individual variation. The gold compounds gold sodium thiomalate (GST) and auranofin (AF) had a bimodal effect on cytokine production. High concentrations of GST (greater than 1 microgram/ml) weakly inhibited IL-1-beta secretion (without affecting IL-1-alpha or TNF secretion and without affecting cell-associated IL-1-alpha and IL-1-beta accumulation), and although AF (greater than 100 ng/ml) inhibited cytokine production it did so at concentrations near to the toxic range for the drug (greater than 200 ng/ml). GST and AF when used in combination inhibited cytokine production in a synergistic manner even at concentrations that would potentiate cytokine production if used individually. Hydroxychloroquine (HCQ) and sulfasalazine (SAP) were two other inhibitory SAARDs which acted synergistically in combination. Combination of HCQ and SAP with gold drugs gave variable results. D-penicillamine (D-pen) and methotrexate (MTX) were two SAARDs that generally did not affect cytokine production individually or in combination with other SAARDs. These results suggest that combination SAARD therapy may more effectively target excessive cytokine production, which is a hallmark of rheumatoid arthritis." @default.
- W96157772 created "2016-06-24" @default.
- W96157772 creator A5034250092 @default.
- W96157772 creator A5049935118 @default.
- W96157772 creator A5078122666 @default.
- W96157772 date "1991-01-01" @default.
- W96157772 modified "2023-09-25" @default.
- W96157772 title "The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro." @default.
- W96157772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1841047" @default.
- W96157772 hasPublicationYear "1991" @default.
- W96157772 type Work @default.
- W96157772 sameAs 96157772 @default.
- W96157772 citedByCount "6" @default.
- W96157772 countsByYear W961577722012 @default.
- W96157772 countsByYear W961577722015 @default.
- W96157772 crossrefType "journal-article" @default.
- W96157772 hasAuthorship W96157772A5034250092 @default.
- W96157772 hasAuthorship W96157772A5049935118 @default.
- W96157772 hasAuthorship W96157772A5078122666 @default.
- W96157772 hasConcept C11988809 @default.
- W96157772 hasConcept C126322002 @default.
- W96157772 hasConcept C17991360 @default.
- W96157772 hasConcept C203014093 @default.
- W96157772 hasConcept C2776243873 @default.
- W96157772 hasConcept C2777575956 @default.
- W96157772 hasConcept C2778690821 @default.
- W96157772 hasConcept C2779123688 @default.
- W96157772 hasConcept C2779134260 @default.
- W96157772 hasConcept C2779348387 @default.
- W96157772 hasConcept C2779383735 @default.
- W96157772 hasConcept C2779603739 @default.
- W96157772 hasConcept C2780479503 @default.
- W96157772 hasConcept C2910020066 @default.
- W96157772 hasConcept C3008058167 @default.
- W96157772 hasConcept C524204448 @default.
- W96157772 hasConcept C71924100 @default.
- W96157772 hasConcept C74172505 @default.
- W96157772 hasConcept C98274493 @default.
- W96157772 hasConceptScore W96157772C11988809 @default.
- W96157772 hasConceptScore W96157772C126322002 @default.
- W96157772 hasConceptScore W96157772C17991360 @default.
- W96157772 hasConceptScore W96157772C203014093 @default.
- W96157772 hasConceptScore W96157772C2776243873 @default.
- W96157772 hasConceptScore W96157772C2777575956 @default.
- W96157772 hasConceptScore W96157772C2778690821 @default.
- W96157772 hasConceptScore W96157772C2779123688 @default.
- W96157772 hasConceptScore W96157772C2779134260 @default.
- W96157772 hasConceptScore W96157772C2779348387 @default.
- W96157772 hasConceptScore W96157772C2779383735 @default.
- W96157772 hasConceptScore W96157772C2779603739 @default.
- W96157772 hasConceptScore W96157772C2780479503 @default.
- W96157772 hasConceptScore W96157772C2910020066 @default.
- W96157772 hasConceptScore W96157772C3008058167 @default.
- W96157772 hasConceptScore W96157772C524204448 @default.
- W96157772 hasConceptScore W96157772C71924100 @default.
- W96157772 hasConceptScore W96157772C74172505 @default.
- W96157772 hasConceptScore W96157772C98274493 @default.
- W96157772 hasIssue "12" @default.
- W96157772 hasLocation W961577721 @default.
- W96157772 hasOpenAccess W96157772 @default.
- W96157772 hasPrimaryLocation W961577721 @default.
- W96157772 hasRelatedWork W1529758829 @default.
- W96157772 hasRelatedWork W1563119347 @default.
- W96157772 hasRelatedWork W1809306142 @default.
- W96157772 hasRelatedWork W1974181706 @default.
- W96157772 hasRelatedWork W1984030504 @default.
- W96157772 hasRelatedWork W1986019584 @default.
- W96157772 hasRelatedWork W2002102442 @default.
- W96157772 hasRelatedWork W2008085055 @default.
- W96157772 hasRelatedWork W2022453432 @default.
- W96157772 hasRelatedWork W2027412145 @default.
- W96157772 hasRelatedWork W2038978522 @default.
- W96157772 hasRelatedWork W2083729333 @default.
- W96157772 hasRelatedWork W2163835098 @default.
- W96157772 hasRelatedWork W2188147365 @default.
- W96157772 hasRelatedWork W2408544642 @default.
- W96157772 hasRelatedWork W2468548062 @default.
- W96157772 hasRelatedWork W2770248754 @default.
- W96157772 hasRelatedWork W2952865880 @default.
- W96157772 hasRelatedWork W42224887 @default.
- W96157772 hasRelatedWork W2416196245 @default.
- W96157772 hasVolume "17" @default.
- W96157772 isParatext "false" @default.
- W96157772 isRetracted "false" @default.
- W96157772 magId "96157772" @default.
- W96157772 workType "article" @default.